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Abstract
By using sophisticated surgical techniques in combination with the Slim Perimodiolar cochlear 
implant electrode array a hitherto unattained high rate of residual hearing preservation in cochlear 
implantation has been observed that makes potential for electric acoustic stimulation. One of the 
primary aims of cochlear implant system engineering is to promote atraumatic electrode insertion 
to maintain optimal postoperative hearing sensitivity by protecting and preserving the delicate 
inner ear structures.
The study aimed to collect pre-, and postoperative audiological and surgical results from the 
experience gained from the applied cochlear implant configuration.
About 30 patients (aged 43.32 ± 24 years) with partial hearing loss were supplied with this atraumatic 
perimodiolar thin electrode which was designed to preserve residual hearing despite intracochlear 
insertion of an electrode array. All patients were implanted with consentaneous CI system and 
surgery technique.
The use of new electrode array profiles in cochlear implantation plays a fundamental role in 
minimally invasive soft surgery, taking into individual needs, and providing long-term acoustic 
hearing preservation. Hearing preservation was achieved in most cases (partial residual hearing 
preservation) after a long-term follow-up period (preoperation, at least one year).
Keywords: Cochlear implantation; Hearing preservation; Soft surgery; Perimodiolar electrode 
profile
Introduction
Competing companies (Advanced Bionics, Cochlear, Med-El and Oticon, etc.) provide different 
types of receiver-stimulators, implant electrodes and speech processors. There are several pros and 
cons when opting for an electrode profile (straight or perimodiolar), cochlear coverage (total or 
partial), receiver-stimulator (physical attributes) and speech processor (electric or electroacoustic 
stimulation), that meet the individual needs. One of the primary aims of cochlear implant system 
engineering is to promote atraumatic electrode insertion to maintain optimal postoperative hearing 
sensitivity by protecting and preserving the delicate inner ear structures.
Residual hearing sensitivity may deteriorate due to perioperative traumas or complications with 
delayed onset. The applied surgical approach (Round Window (RW), Extended Round Window 
(ERW), Cochleostomy (CS)) and the implanted electrode profile mainly lead to immediate or short-
term damage, while delayed alteration in cochlear function usually derives from the fibrous or bony 
remodelling of the endocochlear compartments.
Surgically important properties are the physical attributes of the electrode configuration 
(perimodiolar vs. straight; rounded vs. smoothened tip; short vs. regular; with or without stylet, 
etc.), the type of cochlear fenestration (RW, ERW, CS), the method of electrode insertion (standard 
vs. soft surgery with advance-off-stylet), the use of lubricants or drugs in the cochlea (e.g. intrascalar 
corticosteroids) and the intrascalar position of the electrode array (perimodiolar, mid-scala, lateral-
wall) [1-3].
However, the possible disproportion between the physical dimensions of the electrode profile 
and the endocochlear compartments (diameter, shape, length of scala tympani) play a significant 
role in preserving inner ear structures and functions, too.
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Minimizing the damage in the inner ear enhances the possibility 
for hearing preservation, thus leading to better hearing performance. 
Systemic and/or intratympanic administration of steroids may 
contribute to hearing preservation. The beneficial effects of 
glucocorticoids are thought to be mediated through several different 
pathways: the anti-inflammatory effects; the down-regulation of 
production of inducible nitric-oxide synthase; and direct inhibition 
of the MAP/JNK cell death signal cascade [2-5].
We aimed to study long-term hearing preservation in a non-
randomized, prospective clinical cohort with cochlear implant 
systems, limited to ones produced by Australian and Austrian leader 
companies, provided and fully financed by the Hungarian National 
Health Insurance.
Materials and Methods
Study cohort
Out of the total number of cochlear implantees with slim 
perimodiolar implant system (n=94) our study population was 
recruited on the basis of the following criteria: (1) patient with good 
compliance; (2) measureable preoperative hearing threshold; (3) slim 
perimodiolar electrode array implant system; (4) minimum one-year 
follow-up period. Thirty consecutive subjects were enrolled into this 
prospective, non-randomized clinical study. Twenty females and ten 
males with mean age at implantation of 43.32 years, ranged between 
10 years to 77 years. All subjects were implanted at the University of 
Szeged from 2015 until 2017. The postoperative follow-up duration 
lasted 1.72 years at average (ranged between 1.1 and 2.55 years). All 
subjects met the official indication criteria of Cochlear Implantation 
(CI). Anatomical / structural malformation was not revealed by the 
preoperative radiological examinations. For detailed patient data, 
please see Table 1.
Implant configuration
The studied cochlear implant system has a slim, full-length 
perimodiolar electrode (Figure 1). The thin implant body has no 
pedestal and it is designed to minimize bone excavation and skin 
protrusion. At the implant coil the implant measures 3.7 mm and the 
implant main body measures 3.9 mm in thickness. The side-by-side 
symmetrical shape makes the implantation easier for the surgeon. 
The titanium casing has been used for high impact resistance, and 
the smooth external geometry to minimize biofilm formation, that 
reduces the risk of infection. The 98 mm total length of electrode 
array helps to insert it in a better position, but the main handle assist 
tool is the reloadable sheath for the smooth electrode insertion. The 
thin electrode array allows unobstructed access to the scala tympani 
that has a tip diameter of 0.35 × 0.4 mm and 0.45 × 0.5 mm at the 
base. At the last edge of the electrode array there are three white 
marker rings for controlling the insertion depth that are followed by 
22 half banded platinum electrode contacts. These properties make 
this implant configuration easier to use with shorter incision and 
surgery time. The insertion assistant sheath platform and the physical 
attributes of the electrode array facilitate to proximate the modiolus 
and thus prevent the electrode from dislocation into the scalae media 
or vestibuli [6-8].
Surgical technique
Preserving the residual hearing requires minimally invasive 
techniques of (1) cochlear fenestration, (2) management of 
endocochlear fluid compartments and (3) atraumatic electrode 
insertion, known as soft surgery. Thinner and atraumatic electrode 
arrays are also designed to accomplish these aims, as postoperative 
hearing performance can be maximized by minimizing the insertion 
trauma [3,8-11].
Several important factors contribute to intracochlear damage 
during implantation: (1) direct physical trauma, (2) pressure 
wave propagation in the perilymphatic fluid, (3) vibration and/
or heat trauma from drilling, (4) loss of perilymph, (5) changes 
Figure 1: (A) A traumatic electrode insertion in optimal position with the 
reloadable sheath. (B) Slim, perimodiolar electrode configuration with total 
cochlear coverage.
Figure 2: Skull AP axial on the first postoperative day that confirms the 
proper in situ electrode position. The depicted subject (not included into the 
present study due to completely missing preoperative hearing) was chosen 
to interpret the differences between sequentially implanted systems (A: 
right ear: CI512 Contour Advanced; B: left ear: CI532 Slim Perimodiolar). 
A decreased electrode array curvature is seen with the slim perimodiolar 
system (B).
Figure 3: Number of implantees with measurable hearing threshold at 
different frequencies. Preoperative (striped pattern columns); postoperative 
(checked pattern columns). On the top horizontal axis, the frequency-specific 
success rate of hearing preservation is showed in percentages.
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in homeosthasis/hydrodynamics of the endocochlear fluid 
compartments, (6) delayed fibrotic alteration and new bone formation 
within the cochlear lumen [3,12-16].
The physical attributes (length and diameter) of the electrode 
array may each limit the postoperatively achieved residual hearing 
[17].
Comprehensive analysis of imaging diagnostics of the middle and 
inner ear provide indispensable information for planning the proper 
surgical access route and electrode [17,18].
Soft surgery
The term soft surgery was introduced by Lehnhardt in 1993 and it 
provided basis for numerous publications [9,19].
Our routinely applied minimally invasive surgical technique 
involved electrode insertion via the Round Window (RW). In order 
to reduce bleeding and to prevent blood from accessing the cochlea, 
we filled the tympanic cavity with adrenaline solution after having the 
posterior tympanotomy been completed. To prevent bone fragments 
entering the cochlea, the tympanic and mastoid cavity were flushed 
with abundant amount of saline. To remove the bony overhang of 
the round window, we used a 1 mm diamond burr at low speed (max. 
350 rpm) in order to avoid noise and heat injury. We opened the RW 
membrane with a microscopic needle or hook. After opening the 
inner ear, suction was applied with care in order to avoid reducing 
the amount of perilymph. Furthermore, the scala tympani was left 
open for the shortest possible period, to prevent bone fragments, 
blood or other substances entering the inner ear, which might have 
been sources of primary and/or secondary injuries that finally would 
lead to loss of residual hearing. As a sort of prevention, after having 
opened the RW, we placed a piece of gel-foam soaked in corticosteroid 
solution into the RW niche.
The slim modiolar electrode of the CI532 implant was soaked 
into methylprednisolone solution (40 mg powder dissolved in 10 ml 
saline) and it was retracted into the insertion sheath. The insertion 
sheath together with the electrode array was inserted into the scala 
tympani with the lowest possible force. Any minute resistance felt by 
the surgeon would have indicated physical contact of the electrode 
array to the basilar membrane or the lateral wall of the scala tympani 
or stria vascularis and possible injury of these structures. After the 
electrode had been inserted in full length, indicated by the 1st marker 
ring, the RW was immediately sealed with an autologous tissue (e.g. 
fascia or muscle) in order to prevent loss of perilymph [9].
Radiological validation
Radiography (skull AP axial/Towne view) was performed on the 
first postoperative day to confirm the proper intracochlear electrode 
position (Figure 2).
Pure-tone audiometry
Pure-tone air-conduction thresholds were used to register 
residual hearing with the ascending method, with 5 dBHL intensity 
steps. The audiometer (GSI 61 Clinical Audiometer; Grason-
Stadler, MN USA) was calibrated according to the standards of the 
International Organization for Standardization (ISO 389-1:2017). 
THD-50P (Telephonics Corporation/Griffon Company, NY USA) 
headphone was used for air conduction hearing measurements.
Results
Pre- and postoperative pure tone hearing threshold 
measurements were completed for all the 30 recruited subjects. Figure 
3 frequency-dependently illustrates the number of patients pre- and 
postoperatively, where hearing sensitivity was measurable. It is well 
demonstrated that hearing is the most stable within the 250 to 1000 
Hz range, and the least is beyond 4 kHz. This statement is true either 
pre-, or postoperatively.
Figure 4: Preoperative (striped pattern columns) and postoperative (dotted 
pattern columns) hearing thresholds in dBHL at the measured frequencies 
(*p<0.05).
Figure 5: Loss of acoustic sensitivity interpreted in dBHL ranges, while 
exhibiting the number of implantees frequency-specifically (with different 
patterns of columns).
Figure 6: Preoperative threshold of HP (striped pattern columns, n=number 
of patients) and THL (squared pattern columns, m=number of patients) 
patients (Continuous line measureable threshold level).
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The average preoperative thresholds of the hearing within the 
lower frequency range were 61.75 dBHL at 125 Hz (no response from 
10 patients); 78.52 dBHL at 250 Hz (no response from 3 patients). At 
the middle frequency range, mean values were 88.67 dBHL at 500 Hz 
(response from all patients); 97.07 dBHL at 1 kHz (no response from 
1 patient) and 100.50 dBHL at 2 kHz (no response from 10 patients). 
At the higher frequencies, the average values were 91.36 dBHL at 4 
kHz (no response from 19 patients) and 84.00 dBHL at 8 kHz (no 
response from 25 patients).
The difference in height between the striped and checked pattern 
columns represents the percentage of successful hearing preservation 
at specific frequencies.
One year postoperatively the average values of the hearing 
thresholds at the lower frequency range were: 93.89 dBHL at 125 Hz 
(no response from 17 patients); 87.86 dBHL at 250 Hz (no response 
from 10 patients). At the middle frequencies mean values were 102.86 
dBHL at 500 Hz (no response from 10 patients); 111.61 dBHL at 1 
kHz (no response from 14 patients) and 113.75 dBHL at 2 kHz (no 
response from 21 patients). At the higher frequencies, average values 
were 115.18 dBHL at 4 kHz (no response from 24 patients) and 99.29 
dBHL at 8 kHz (no response from 29 patients).
Figure 4 illustrates the preoperative (striped pattern columns) 
and the postoperative (dotted pattern columns) hearing thresholds 
in dBHL at the measured frequencies. Decrease was detected at each 
examined frequencies but the grade of it varied. The highest decrease 
was measured at 500 Hz with an average decrease of 14.19 dBHL and 
at 1000 Hz with an average decrease of 13.77 dBHL. At the lower 
frequency range, hearing remained substantially stable. At 125 Hz 
only 3.06 dBHL, while at 250 Hz only 7.19 dBHL loss was detected. At 
the high frequencies, from 2 to 8 kHz preoperative hearing sensitivity 
had been already proved to be rather poor, thus further loss had just 
little consequences.
Figure 5 frequency-specifically demonstrates the degree of loss of 
acoustic sensitivity grouped into dBHL ranges, while exhibiting the 
No. Gender Age (year) Implanted ear Hearing Loss w/wo genetic origin Total Hearing Loss (THL) after implantation
1 Male 55 Left No No
2 Male 59 Left Yes Yes
3 Male 16 Right No No
4 Male 24 Right No No
5 Male 15 Left No Yes
6 Male 72 Right No No
7 Female 70 Right No No
8 Female 71 Left No No
9 Female 10 Right Yes Yes
10 Male 11 Right No No
11 Female 43 Left Yes Yes
12 Female 28 Right No No
13 Female 28 Left No No
14 Female 11 Right No No
15 Female 70 Right No No
16 Female 24 Right No No
17 Male 62 Right No No
18 Female 77 Right No No
19 Female 42 Right No No
20 Female 48 Right No Yes
21 Female 71 Left No No
22 Female 53 Right No Yes
23 Female 59 Right No No
24 Male 13 Right No No
25 Female 27 Right No No
26 Female 35 Left No Yes
27 Female 59 Left No No
28 Female 30 Right No No
29 Male 53 Right No No
30 Male 69 Right No Yes
Average Male=10 Female=20 (Mean ± SD) 43.32 ± 24 Right=21 Left=9
Genetic disorder=3
No evidence=27
THL=7
Table 1: Population of study patients.
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number of implantees. It is clearly shown that only minute threshold 
decay with less than 5 dBHL loss is the most frequently found one, 
while prominent postoperative loss of hearing appears less often.
Subjects with complete loss of hearing following surgery
Nine implantees (9/30=30%) showed up with total loss of 
residual hearing at every measured frequency following surgery. 
Their preoperative hearing sensitivity is presented in Figure 6. It is 
clearly seen that within this subgroup of this cohort the measured 
average hearing threshold have been already poorer prior to surgery 
compared to those with preserved hearing. Genetic screening of 
the 30 recruited subjects revealed mutations in three cases in the 
background of hearing loss. All of these subjects suffered complete 
hearing loss postoperatively (3/3=100%), that genetic alteration 
may serve as a predictor when opting for an electro-acoustic/hybrid 
device, should be taken into consideration when indicating these 
systems [20].
Discussion
Preservation of acoustic hearing associated with cochlear 
implantation improves the postoperatively achievable periodicity 
and spectral resolution, which improves the patient's speech 
comprehension and the localization of the tone in particularly 
difficult conditions [21-26].
The effects of cochlear implantation on residual hearing have 
been discussed in several studies in which a number of surgical and 
technical factors have been identified [27]. There are some surgical 
techniques of approaching the scala tympani (i.e., RW, ERW, CS) 
with varying risks of harming the fine structures of the cochlea 
with prompt or delayed onset [13]. Such late complications, like the 
appearance of endocochlear connective tissue or new bone formation, 
may lead to a gradual partial or complete loss of residual acoustic 
hearing [28]. This is most likely to be seen when the round window 
is extendedly exposed, where endothelial lesions trigger new tissue 
proliferation. The slightest is the tendency to harm the endocochlear 
structures when minimally invasive, soft surgery is applied [13].
Physical attributes of the electrode profile may also interfere with 
postoperative cochlear function. Theoretically, the endocochlear 
hydrodynamics may also be altered, as the vibration of the basilar 
membrane is restricted due to the presence of an electrode array. At 
this point, as the travelling waves to the apical region are modified, 
the basilar membrane would react to sounds differently, leading to an 
endocochlear “conductive” hearing loss [29, 30].
The new type of thin-diameter electrode arrays close to the 
modiolus are expected to have a lower hydrodynamic load, since the 
bony spiral lamina is attached from below, thus the basilar membrane 
vibrations remain unrestricted. However, the perimodiolar position 
of the electrode array allows the adjacent nerve elements of the spiral 
ganglion to be stimulated with a lower electrical intensity and through 
a smaller surface.
Cadaver experiments demonstrated that a force, applied to the 
basilar membrane with an average of 88 mN (42 mN to 122 mN) 
would be sufficient to accomplish the interscalar dislocation of the 
electrode, of which manual perceptibility is questionable [31]. Studies 
with large case numbers (n=100) have shown that the probability 
of the electrode line being located in the scala vestibuli significantly 
increased during CS, which also manifested itself in the absence of 
improvement in speech comprehension [32].
In a number of studies, intraoperatively performed electro-
cochleography is used to track the electrode insertional trauma, 
furthermore to postoperative residual hearing follow-ups [33-35].
For the implementation of Electro-Acoustic (EAS) or hybrid 
speech processors the long-term preservation of residual acoustic 
hearing is inherently inevitable, thus application of atraumatic 
surgical techniques and electrode arrays is essential.
Our study cohort obviously demonstrates that by the application 
of appropriate soft surgery techniques and atraumatic electrodes are 
able to retain residual hearing on a long run. The positive experience 
gained with the new type of CI532 Slim Modiolar electrode predicts 
the possibility for the preservation of structural and functional 
integrity of all cochlear regions. Furthermore, a prompt, definitive 
solution could be provided for a possible late hearing loss progression, 
where only a psychophysical reprogramming of the implant would be 
enough.
On the basis of our results, if the acoustic hearing loss can be 
preserved with the assurance and efficacy of the initial experience, 
we will be able to provide sustained prominent hearing rehabilitation 
even in the indication of EAS that results in significant improvement 
in the life quality of many implantees.
In addition, long-term residual hearing loss may be of crucial 
importance in the subsequent feasibility of regenerative procedures 
and medical treatments [3,7,36,37].
Conclusion
In cochlear implantation, the use of new electrode array profiles 
plays a fundamental role in minimally invasive soft surgery, taking 
into individual needs, and providing long-term acoustic hearing 
preservation. Our study demonstrates the efficacy of the Nucleus 
CI532 Slim Modiolar electrode profile and it has the potential for 
granting residual hearing, which predicts the possible use of this 
configuration as part of EAS systems and makes it available for future 
treatments, i.e., the regeneration-based new therapeutic approaches 
of intracochlear hair-cells.
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